Dice Therapeutics, Inc. (DICE)

Number of records: 37
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
09-Aug-23 4:29 PM
View: 
Scheller Richard H
Director
Dice Therapeutics, Inc. (DICE) 09-Aug-23Disposition 8,427----(100%)
8.43K to 0
09-Aug-23 4:31 PM
View: 
Robertson Scott M.
CFO & CBO
Dice Therapeutics, Inc. (DICE) 09-Aug-23Disposition 198,000----(100%)
198.0K to 0
09-Aug-23 5:00 PM
View: 
Ra Capital Management, LLC
Dice Therapeutics, Inc. (DICE) 09-Aug-23Disposition (change in control) 7,856,610----(100%)
7.86M to 0
09-Aug-23 4:25 PM
View: 
Judice Kevin
CEO
Director
Dice Therapeutics, Inc. (DICE) 09-Aug-23Disposition 799,685----(100%)
799.68K to 0
09-Aug-23 4:33 PM
View: 
Scopa James Paul
Director
Dice Therapeutics, Inc. (DICE) 09-Aug-23Disposition 15,199----(37%)
40.92K to 25.72K
09-Aug-23 4:38 PM
View: 
Tetlow Sharon
Director
Dice Therapeutics, Inc. (DICE) 09-Aug-23Disposition 49,841----(100%)
49.84K to 0
09-Aug-23 4:23 PM
View: 
Jacobsen John R.
CSO
Dice Therapeutics, Inc. (DICE) 09-Aug-23Disposition 147,497----(100%)
147.5K to 0
09-Aug-23 4:26 PM
View: 
Timothy Lu
CMO
Dice Therapeutics, Inc. (DICE) 09-Aug-23Disposition 152,285----(100%)
152.28K to 0
09-Aug-23 4:33 PM
View: 
Scopa James Paul
Director
Dice Therapeutics, Inc. (DICE) 09-Aug-23Disposition 25,722----(100%)
25.72K to 0
03-Aug-23 7:37 PM
View: 
Scopa James Paul
Director
Dice Therapeutics, Inc. (DICE) 02-Aug-23Gift 2,420----(6%)
43.34K to 40.92K
19-Jul-23 4:53 PM
View: 
Scopa James Paul
Director
Dice Therapeutics, Inc. (DICE) 18-Jul-23Gift 2,200----(5%)
45.54K to 43.34K
13-Jul-23 5:12 PM
View: 
Scopa James Paul
Director
Dice Therapeutics, Inc. (DICE) 11-Jul-23Gift 300----(< 1%)
45.84K to 45.54K
23-Jun-23 5:36 PM
View: 
Northpond Ventures Gp, LLC
10% Owner
Dice Therapeutics, Inc. (DICE) 22-Jun-23Private Sale 2,492,870$46.50$115,919,000.00(76%)
3.29M to 800.0K
02-Jun-23 8:11 PM
View: 
Jacobsen John R.
CSO
Dice Therapeutics, Inc. (DICE) 01-Jun-23Private Sale (Planned) 18,750$30.53$572,444.00(11%)
166.25K to 147.5K
09-May-23 6:02 PM
View: 
Scheller Richard H
Director
Dice Therapeutics, Inc. (DICE) 05-May-23Private Sale (Planned) 84,097$38.51$3,238,210.00(91%)
92.52K to 8.43K
05-May-23 5:10 PM
View: 
Timothy Lu
CMO
Dice Therapeutics, Inc. (DICE) 03-May-23Private Sale (Planned) 10,000$36.54$365,398.00(6%)
162.28K to 152.28K
05-May-23 5:19 PM
View: 
Robertson Scott M.
CFO & CBO
Dice Therapeutics, Inc. (DICE) 03-May-23Private Sale (Planned) 18,750$36.55$685,350.00(9%)
216.75K to 198.0K
05-May-23 5:03 PM
View: 
Judice Kevin
CEO
Director
Dice Therapeutics, Inc. (DICE) 03-May-23Private Sale (Planned) 13,698$36.50$499,977.00(2%)
813.38K to 799.68K
19-Apr-23 7:28 PM
View: 
Jacobsen John R.
CSO
Dice Therapeutics, Inc. (DICE) 18-Apr-23Private Sale (Planned) 16,392$30.08$493,127.00(9%)
182.64K to 166.25K
04-Apr-23 5:31 PM
View: 
Jacobsen John R.
CSO
Dice Therapeutics, Inc. (DICE) 31-Mar-23Private Sale (Planned) 773$30.00$23,190.00(< 1%)
183.41K to 182.64K
30-Mar-23 5:03 PM
View: 
Ra Capital Management, LLC
Director
10% Owner
Dice Therapeutics, Inc. (DICE) 30-Mar-23Purchase 195,997$28.74$5,632,950.00< 1%
21.34M to 21.54M
30-Mar-23 5:03 PM
View: 
Ra Capital Management, LLC
Director
10% Owner
Dice Therapeutics, Inc. (DICE) 29-Mar-23Purchase 66,369$29.38$1,949,920.00< 1%
21.28M to 21.34M
30-Mar-23 4:35 PM
View: 
Jacobsen John R.
CSO
Dice Therapeutics, Inc. (DICE) 29-Mar-23Sale (Planned) 1,094$30.00$32,822.80(< 1%)
184.51K to 183.41K
30-Mar-23 5:03 PM
View: 
Ra Capital Management, LLC
Director
10% Owner
Dice Therapeutics, Inc. (DICE) 28-Mar-23Purchase 246,779$29.24$7,215,820.001%
21.03M to 21.28M
30-Mar-23 4:35 PM
View: 
Jacobsen John R.
CSO
Dice Therapeutics, Inc. (DICE) 28-Mar-23Private Sale (Planned) 500$30.09$15,044.20(< 1%)
185.01K to 184.51K
27-Mar-23 5:01 PM
View: 
Ra Capital Management, LLC
Director
10% Owner
Dice Therapeutics, Inc. (DICE) 27-Mar-23Purchase 151,132$27.48$4,153,110.00< 1%
19.82M to 19.98M
27-Mar-23 5:01 PM
View: 
Ra Capital Management, LLC
Director
10% Owner
Dice Therapeutics, Inc. (DICE) 24-Mar-23Purchase 192,335$26.87$5,168,040.00< 1%
19.63M to 19.82M
27-Mar-23 5:01 PM
View: 
Ra Capital Management, LLC
Director
10% Owner
Dice Therapeutics, Inc. (DICE) 23-Mar-23Purchase 155,089$26.67$4,136,220.00< 1%
19.48M to 19.63M
21-Mar-23 4:47 PM
View: 
Scopa James Paul
Director
Dice Therapeutics, Inc. (DICE) 17-Mar-23Sale 10,000$29.05$290,500.00(18%)
55.84K to 45.84K
21-Mar-23 4:47 PM
View: 
Scopa James Paul
Director
Dice Therapeutics, Inc. (DICE) 24-Oct-22Gift 30,719----55%
55.84K to 86.56K
21-Mar-23 4:47 PM
View: 
Scopa James Paul
Director
Dice Therapeutics, Inc. (DICE) 24-Oct-22Gift 30,719----(35%)
86.56K to 55.84K
19-Oct-22 4:32 PM
View: 
Ra Capital Management, LLC
Director
10% Owner
Dice Therapeutics, Inc. (DICE) 17-Oct-22Purchase 1,640,000$36.50$59,860,000.0031%
5.21M to 6.85M
20-Sep-21 4:30 PM
View: 
Ra Capital Management, LLC
Director
10% Owner
Dice Therapeutics, Inc. (DICE) 17-Sep-21Conversion 3,808,910----100%
0 to 3.81M
20-Sep-21 9:19 PM
View: 
Northpond Ventures Gp, LLC
10% Owner
Dice Therapeutics, Inc. (DICE) 17-Sep-21Conversion 3,057,870----117%
2.6M to 5.66M
20-Sep-21 4:30 PM
View: 
Ra Capital Management, LLC
Director
10% Owner
Dice Therapeutics, Inc. (DICE) 17-Sep-21Private Purchase 1,400,000$17.00$23,800,000.0037%
3.81M to 5.21M
20-Sep-21 9:19 PM
View: 
Northpond Ventures Gp, LLC
10% Owner
Dice Therapeutics, Inc. (DICE) 17-Sep-21Private Purchase 235,000$17.00$3,995,000.004%
5.66M to 5.9M
16-Sep-21 9:30 PM
View: 
Scopa James Paul
Director
Dice Therapeutics, Inc. (DICE) 15-Sep-21Purchase 6,000$17.00$102,000.0012%
49.84K to 55.84K